Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion type Assertion NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_head.
- NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion description "[A combination of MRK-003 and gemcitabine showed enhanced antitumor effects compared with gemcitabine in 4 of 9 (44%) PDAC xenografts, reduced tumor cell proliferation, and induced both apoptosis and intratumoral necrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_provenance.
- NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion evidence source_evidence_literature NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_provenance.
- NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion SIO_000772 22752426 NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_provenance.
- NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion wasDerivedFrom befree-2016 NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_provenance.
- NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_assertion wasGeneratedBy ECO_0000203 NP994597.RA7GpCnzY9LqpnBZ6Qe4cXig3Ob_nN10805JEO7Js1qPE130_provenance.